Literature DB >> 19426421

Continuous renal replacement therapy in sepsis and multisystem organ failure.

Michael Joannidis1.   

Abstract

This study reviews the role of continuous renal replacement therapy (CRRT) in sepsis with acute kidney injury (AKI) and septic shock with multiple organ failure. In addition to the conventional aim of replacing renal function in AKI, CRRT is often used with the concept of modulating immune response in sepsis. With the intention of influencing circulating levels of inflammatory mediators like cytokines and chemokines, the complement system, as well as factors of the coagulation system, several modifications of CRRT have been developed over the last years. These include high volume hemofiltration, high adsorption hemofiltration, use of high cut-off membranes, and hybrid systems like coupled plasma filtration absorbance. One of the most promising concepts may be the development of renal assist devices using renal tubular cells for implementing renal tubular function into CRRT.

Entities:  

Mesh:

Year:  2009        PMID: 19426421     DOI: 10.1111/j.1525-139X.2008.00552.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  16 in total

Review 1.  Blood purification and mortality in sepsis: a meta-analysis of randomized trials.

Authors:  Feihu Zhou; Zhiyong Peng; Raghavan Murugan; John A Kellum
Journal:  Crit Care Med       Date:  2013-09       Impact factor: 7.598

2.  Management of renal replacement therapy in ICU patients: an international survey.

Authors:  Matthieu Legrand; Michael Darmon; Michael Joannidis; Didier Payen
Journal:  Intensive Care Med       Date:  2012-09-22       Impact factor: 17.440

Review 3.  Continuous renal replacement therapies: a brief primer for the neurointensivist.

Authors:  Pritesh Patel; Veena Nandwani; Paul J McCarthy; Steven A Conrad; L Keith Scott
Journal:  Neurocrit Care       Date:  2010-10       Impact factor: 3.210

4.  Blood hemoperfusion with resin adsorption combined continuous veno-venous hemofiltration for patients with multiple organ dysfunction syndrome.

Authors:  Lu-Yi Liu; Yong-Jian Zhu; Xiao-Li Li; Ya-Feng Liang; Zuo-Peng Liang; Yong-Hong Xia
Journal:  World J Emerg Med       Date:  2012

5.  Cardiorenal syndromes and sepsis.

Authors:  C Chelazzi; G Villa; A R De Gaudio
Journal:  Int J Nephrol       Date:  2011-03-30

Review 6.  Clinical review: timing of renal replacement therapy.

Authors:  Michael Joannidis; Lui G Forni
Journal:  Crit Care       Date:  2011-06-10       Impact factor: 9.097

7.  Lactate clearance is associated with mortality in septic patients with acute kidney injury requiring continuous renal replacement therapy: A cohort study.

Authors:  Rogério da Hora Passos; Joao Gabriel Rosa Ramos; André Gobatto; Evandro José Bulhões Mendonça; Eva Alves Miranda; Fábio Ricardo Dantas Dutra; Maria Fernanda R Coelho; Andrea C Pedroza; Paulo Benigno Pena Batista; Margarida Maria Dantas Dutra
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

8.  Use of Hemadsorption in a Case of Pediatric Toxic Shock Syndrome.

Authors:  Andrea Berkes; Edit Szikszay; János Kappelmayer; Adrienne Kerényi; Tamás Szabó; László Ujhelyi; Krisztina Bari; György Balla; József Balla
Journal:  Case Rep Crit Care       Date:  2017-07-16

Review 9.  High-volume haemofiltration for sepsis in adults.

Authors:  Emma Mj Borthwick; Christopher J Hill; Kannaiyan S Rabindranath; Alexander P Maxwell; Danny F McAuley; Bronagh Blackwood
Journal:  Cochrane Database Syst Rev       Date:  2017-01-31

10.  Electrolyte and mineral disturbances in septic acute kidney injury patients undergoing continuous renal replacement therapy.

Authors:  Su-Young Jung; Hyunwook Kim; Seohyun Park; Jong Hyun Jhee; Hae-Ryong Yun; Hyoungnae Kim; Youn Kyung Kee; Chang-Yun Yoon; Hyung Jung Oh; Tae Ik Chang; Jung Tak Park; Tae-Hyun Yoo; Shin-Wook Kang; Hajeong Lee; Dong Ki Kim; Seung Hyeok Han
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.